EarningsNerd
← Back

SUPERNUS PHARMACEUTICALS, INC.

SUPN
$47.64+1.88%

SEC Filings

Recommended10-Q · Aug 3, 2026

Not sure where to start? This is SUPERNUS PHARMACEUTICALS, INC.'s most recent filing. Start with its AI summary.

Summarize this filing
10-QRecommendedAug 3, 2026
View on SEC EDGARGenerate Filing Summary
10-QMay 5, 2026
View on SEC EDGARGenerate Filing Summary
10-KMar 2, 2026
View on SEC EDGARGenerate Filing Summary
10-QNov 6, 2025
View on SEC EDGARGenerate Filing Summary
10-QAug 5, 2025
View on SEC EDGARGenerate Filing Summary
10-QMay 6, 2025
View on SEC EDGARGenerate Filing Summary
10-KFeb 25, 2025
View on SEC EDGARGenerate Filing Summary
10-QNov 4, 2024
View on SEC EDGARGenerate Filing Summary
10-QAug 6, 2024
View on SEC EDGARGenerate Filing Summary
10-QMay 8, 2024
View on SEC EDGARGenerate Filing Summary

Showing filings since Nov 5, 2021. Full history on SEC EDGAR